VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
WARGO, JENNIFER
One or more keywords matched the following items that are connected to
WARGO, JENNIFER
Item Type
Name
Academic Article
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade.
Academic Article
Loss of IFN-? Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.
Academic Article
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
Academic Article
Diverse types of dermatologic toxicities from immune checkpoint blockade therapy.
Academic Article
Interaction of molecular alterations with immune response in melanoma.
Academic Article
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer.
Academic Article
Hallmarks of response to immune checkpoint blockade.
Academic Article
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.
Academic Article
Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab.
Academic Article
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers.
Academic Article
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.
Academic Article
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Concept
Ipilimumab
Academic Article
Neoadjuvant therapy for melanoma: is it ready for prime time?
Academic Article
Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).
Academic Article
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
Academic Article
Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1.
Academic Article
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
Academic Article
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.
Search Criteria
Ipilimumab